6
Oct
2026
25
May
2027
Piramal Pharma Solutions
About Piramal Pharma Solutions
Certifications
-
FDA -
GMP
Categories
Meet us at
-
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026stand 10F57 -
CPHI Americas 2027
Miami Beach Convention Center, Florida
25 May 2027 - 26 May 2027stand 649
-
Country/Region:United States
-
Founded:1988
-
On CPHI since:2017
-
Certificates:3
-
Employees:5000+
Company types
Primary activities
Contact info
-
-
-
18655 Krause Street, Riverview MI, 48193, Riverview, MI\ USA, United States
Piramal Pharma Solutions Resources (23)
-
Brochure Patient Centricity Quick Facts Sheet
Patient Centricity Quick Facts Sheet -
Brochure Regulatory Services Quick Facts Sheet
Regulatory Services Quick Facts Sheet -
Brochure Piramal Pharma Solutions Peptides Quick Facts Sheet
Piramal Pharma Solutions Peptides Overview -
Brochure Vaccines & Biologics Quick Facts Sheet
Vaccines & Biologics Quick Facts Sheet -
Brochure Biotech Quick Facts Sheet
Biotech Quick Facts Sheet -
Brochure ADCelerate Quick Facts Sheet
ADC Quick Facts Sheet -
Brochure Piramal Pharma Solutions Formulations
Piramal Pharma Solutions Formulations brochure -
Brochure Piramal Pharma Solutions Integration Service Offerings
Piramal Pharma Solutions Integration Service Offerings Brochure -
Brochure Piramal Pharma Solutions Global Capabilities Brochure
Piramal Pharma Solutions Global Capabilities Brochure -
Brochure Antibody Drug Conjugation Services
Antibody-Drug Conjugation (ADC) Services Brochure -
Brochure Global Capabilities Brochure
Explore our global network of sites and capabilities designed to support your molecule from discovery through commercialization -
Video 6 Reasons to Make our Riverview site Your API Partner
For over 60 years, our Riverview, Michigan facility has been a global leader in drug substance development and manufacturing, offering comprehensive services from early development to commercialization. This includes specialized solutions for HPAPIs and payload-linkers, enabling Riverview to support complex programs across diverse therapeutic areas. All this – backed by an exceptional regulatory record, a recent facility expansion, and 18 successful API launches. Watch the video to learn why Riverview is the partner your next API program needs. -
Video Meet Conor Barry, Global Head of Bioconjugates Development from our Science Collective.
Meet Conor Barry, Global Head of Bioconjugates Development at Piramal Pharma Solutions (PPS). With over 15 years of scientific experience, Conor shares insights into the rapid evolution of targeted therapeutics and the expanding potential of bioconjugates. Beyond the 15 approved ADCs (Antibody-Drug Conjugates) used in cancer treatment, the field is advancing into applications beyond oncology, including antibody-oligonucleotide conjugates and targeted radiotherapies. As part of the PPS Science Collective, Conor highlights PPS’s commitment to advancing life-changing therapies. Over nearly 20 years, PPS has supported clients in advancing more than 40 bioconjugates into clinical trials and two into commercial production.
-
Brochure ADCelerate, Rapid, Integration ADC to IND
ADCelerate is Piramal Pharma Solutions’ rapid approach to delivering Phase-I appropriate ADC drug substance and drug product -
Brochure Yapan_Vaccines_and_Biologics_Quick_Facts_Sheet
Vaccines_and_Biologics_Quick_Facts_Sheet -
Brochure Generic Peptide APIs Peptides for Toxicology & Clinical Trials
Generic Peptide APIs Peptides for Toxicology & Clinical Trials -
Brochure Antibody Drug Conjugate Services
Explore our integrated ADC development and manufacturing services, designed to take your molecule from concept to clinic with speed and precision. -
Brochure ADC_Quick_Facts_Sheet
ADCelerate Quick Facts Sheet -
Brochure Delivering Integrated Solutions Across The Drug Life Cycle
Piramal Pharma Solutions (PPS) is a leading global CDMO offering integrated services across the entire drug life cycle, from discovery and development to commercial manufacturing. Through a network of 15 facilities across North America, Europe, and India, PPS provides expertise in APIs, formulations, clinical trial supplies, sterile injectables, HPAPIs, ADCs, peptides, biologics, vaccines, and specialty therapeutics. Backed by over 5,300 employees, robust scientific expertise, and a patient-centric approach, PPS helps pharmaceutical and biotech companies accelerate development timelines, reduce complexity, and bring innovative therapies to patients worldwide through flexible, end-to-end solutions. -
Brochure Piramal Pharma Solutions Formulation Services
Piramal Pharma Solutions (PPS) offers integrated formulation development and manufacturing services to support pharmaceutical programs from preclinical development through commercialization. Our global network provides expertise in oral solids, sterile injectables, liquid formulations, clinical trial supplies, specialized formulations, ADCs, and lifecycle management. With state-of-the-art facilities across the US, UK, and India, we combine scientific excellence, regulatory expertise, and flexible manufacturing capabilities to help accelerate the development and delivery of innovative therapies to patients worldwide. Discover how PPS can support your formulation journey from concept to commercial success. -
Video Piramal Pharma announces $85M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky
Investment plan will add commercial scale sterile injectables capabilities Expansion will significantly increase production capacity and operational efficiency Lexington facility now better capable of supporting increased market demand #piramalpharma,#cdmo,#globalcdmo,#expansion -
Video Every Step, Every Story, Every Site —Driven by Patients. Patient Centricity Week Celebrations.
Each year, we observe Patient Centricity Week during the week of September 17th, aligning with the World Health Organization’s World Patient Safety Day. This annual event serves as a powerful reminder of our shared responsibility to uphold the highest standards of quality and safety in everything we do. -
Video 6 Reasons to Partner with Piramal Aurora on APIs
Piramal Pharma Solutions' Aurora facility excels in the process/route selection, process development, and cGMP and non-GMP manufacturing of APIs. With extensive expertise across phases and specialized capabilities for every unique challenge, the Aurora site has successfully launched 15 APIs to date. Watch the video to discover why Aurora is the ideal partner for your next API project!